Trulieve Cannabis Corp.

OTCPK:TCNN.F Stock Report

Market Cap: US$923.5m

Trulieve Cannabis Past Earnings Performance

Past criteria checks 0/6

Trulieve Cannabis's earnings have been declining at an average annual rate of -61.5%, while the Pharmaceuticals industry saw earnings growing at 1.2% annually. Revenues have been growing at an average rate of 25.7% per year.

Key information

-61.5%

Earnings growth rate

-61.2%

EPS growth rate

Pharmaceuticals Industry Growth6.0%
Revenue growth rate25.7%
Return on equity-10.0%
Net Margin-10.7%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Trulieve Cannabis makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

OTCPK:TCNN.F Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,172-1264490
30 Jun 241,163-903940
31 Mar 241,142-4193870
31 Dec 231,129-4313860
30 Sep 231,141-4584220
30 Jun 231,161-5084270
31 Mar 231,193-1854260
31 Dec 221,218-1794220
30 Sep 221,225-1854080
30 Jun 221,153-953760
31 Mar 221,055-373390
31 Dec 21932312960
30 Sep 21801932290
30 Jun 21714912020
31 Mar 21619691790
31 Dec 20522631510
30 Sep 20433-191320
30 Jun 20367231110
31 Mar 2030462910
31 Dec 1925353730
30 Sep 19209128700
30 Jun 1916785600
31 Mar 1913236510
31 Dec 1810311440
30 Sep 188033230
30 Jun 185516170
31 Mar 18339120
31 Dec 1720480
31 Dec 160-410

Quality Earnings: TCNN.F is currently unprofitable.

Growing Profit Margin: TCNN.F is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: TCNN.F is unprofitable, and losses have increased over the past 5 years at a rate of 61.5% per year.

Accelerating Growth: Unable to compare TCNN.F's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: TCNN.F is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (54.6%).

Return on Equity

High ROE: TCNN.F has a negative Return on Equity (-10.01%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 16:16
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Trulieve Cannabis Corp. is covered by 26 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Aaron GreyAlliance Global Partners
Frederico Yokota Choucair GomesATB Capital Markets
Kenric TygheATB Capital Markets